Effects of adjusting for censoring on meta-analyses of time-to-event outcomes
Open Access
- 1 February 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 31 (1) , 107-111
- https://doi.org/10.1093/ije/31.1.107
Abstract
Background Systematic reviews of published time-to-event outcomes commonly rely on calculating odds ratios (OR) at fixed points in time and where actual numbers at risk are not presented. These estimates are usually based on the total numbers included in the published analysis and take no account of censoring. We have assessed the impact of adjusting for censoring on weighting, estimates and statistical heterogeneity of meta-analyses in cancer. Methods Meta-analyses of survival data for five meta-analyses of published trials in cancer were conducted. The OR and associated statistics were calculated based on unadjusted total numbers of participants and events. These were compared with calculations that first adjusted the numbers at risk for censoring using a simple model. Results Pooled OR were changed in 17/24 cases. On average, there was a 2.6% difference between the adjusted and unadjusted OR. Confidence intervals were frequently wider for the adjusted OR. Adjusting also reduced weighting of individual trials with immature follow-up. In 18/24 cases, adjusting reduced statistical heterogeneity and affected the associated P-values. Conclusions Reviewers conducting meta-analyses of published time-to-event data where actual numbers at risk are not available should adjust the numbers at risk, estimated from total numbers analysed, to account for immature data and censoring.Keywords
This publication has 6 references indexed in Scilit:
- Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?European Journal Of Cancer, 1999
- Extracting summary statistics to perform meta-analyses of the published literature for survival endpointsStatistics in Medicine, 1998
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998
- CENSORING ISSUES IN SURVIVAL ANALYSISAnnual Review of Public Health, 1997
- Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials*British Journal of Urology, 1995
- Meta-analysis of the literature or of individual patient data: is there a difference?The Lancet, 1993